Novel Neuroimage Study in Tauopathies With Parkinsonism

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Parkinsonism
Interventions
DRUG

F-18

Totally 60 subjects age 20-80 including 20 subjects with a diagnosis of PD,PSP,and CBS. For disease subjects, caregiver should be able to report activities of daily living and their mental status. Patient should be able to give informed consent or have a caregiver give consent with subject assent.

Trial Locations (1)

333

Chang Gung Memorial Hospital,Linkou, Taoyuan

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT03386669 - Novel Neuroimage Study in Tauopathies With Parkinsonism | Biotech Hunter | Biotech Hunter